体位性血压变化与高血压强化血压管理的关系
该研究为SPRINT试验的事后分析,纳入9329例高血压患者,评估基线体位性血压变化与主要不良心血管事件(MACE)的关联。发现体位性血压变化与MACE呈U形关系,最低风险点约在0 mm Hg;体位性舒张压升高和收缩压降低与MACE风险增加相关。强化血压管理的获益在不同体位性血压变化范围内一致。
要点
- 体位性血压变化与MACE风险呈U形关系,最低风险点约0 mm Hg。
- 体位性舒张压升高和收缩压降低与MACE风险增加相关。
- 强化血压管理的获益在不同体位性血压变化范围内无显著交互作用。
核心结论
- 体位性舒张压升高和收缩压降低与MACE风险增加相关。
- 强化血压管理的获益在不同体位性血压变化范围内一致。
研究设计与样本
- SPRINT试验的事后分析,纳入9329例高血压患者。
- SPRINT为两臂、多中心、随机临床试验,旨在验证强化治疗将收缩压降至<120 mm Hg是否降低心血管疾病风险。
- 体位性血压变化定义为基线站立收缩压减基线平均坐位收缩压,或舒张压减基线平均坐位舒张压。
主要发现
- 体位性血压变化与MACE发生呈U形关系,所有最低风险点约在0 mm Hg。
- inflection点左侧,MACE风险随体位性血压变化减小而降低:收缩压变化HR=0.99,95%CI 0.98-1.00,p=0.04;舒张压变化HR=0.97,95%CI 0.95-0.99,p<0.01。
- inflection点右侧,MACE风险随体位性血压变化增大而增加:收缩压变化HR=1.02,95%CI 1.01-1.06,p<0.01;舒张压变化HR=1.01,95%CI 1.00-1.03,p=0.16。
- 体位性收缩压变化(交互p=0.37)或舒张压变化(交互p=0.33)与强化血压管理之间无显著交互作用。
临床怎么用
- 在高血压管理中,评估体位性血压变化有助于识别MACE风险较高的患者。
- 强化血压管理的获益不受体位性血压变化范围影响,可考虑个体化应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated that closely controlling blood pressure (BP) could decrease cardiovascular outcome risk without increasing the orthostatic hypotension rate. We aimed to evaluate the association between baseline orthostatic BP change and major adverse cardiovascular event (MACE) occurrence. METHODS: We conducted a post hoc analysis using SPRINT data including 9329 patients with hypertension. The SPRINT trial was a two-arm, multicentre, randomised clinical trial designed to test whether an intensive treatment aimed at reducing systolic BP (SBP) to <120 mm Hg would reduce cardiovascular disease risk. Orthostatic BP change was defined as baseline standing systolic BP (SBP)-baseline mean seated SBP, or diastolic BP (DBP)-baseline mean seated DBP. RESULTS: We found a U-shaped relationship between orthostatic BP changes and MACE occurrence. All lowest risk points were around 0 mm Hg. On the left side of the inflection point, MACE risk decreased with orthostatic BP change decrease (HR=0.99, 95% CI (0.98 to 1.00), p=0.04, SBP change) (HR=0.97, 95% CI (0.95 to 0.99), p<0.01, DBP change); on the right side, MACE risk increased with orthostatic BP change increase (HR=1.02, 95% CI (1.01 to 1.06), p<0.01, SBP change) (HR=1.01, 95% CI (1.00 to 1.03), p=0.16, DBP change). There was no significant interaction effect between orthostatic SBP (p for interaction=0.37) or DBP changes (p for interaction=0.33) and intensive BP management. CONCLUSIONS: Orthostatic DBP increase and SBP decrease were associated with an increased MACE risk. The benefits of intensive BP management were also consistent across different orthostatic BP change ranges.
引用
- Pei J, Zhang H, Li Y, et al. Relationship between orthostatic blood pressure changes and intensive blood pressure management in patients with hypertension. Heart. 2022. PMID: 36007937. doi:10.1136/heartjnl-2022-321276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。